Skip to main content

TEVA 7306 Pill - orange & white capsule/oblong, 14mm

Pill with imprint TEVA 7306 is Orange & White, Capsule/Oblong and has been identified as Celecoxib 50 mg. It is supplied by Teva Pharmaceuticals USA Inc.

Celecoxib is used in the treatment of Ankylosing Spondylitis; Osteoarthritis; Chronic Pain; Familial Adenomatous Polyposis; Juvenile Rheumatoid Arthritis and belongs to the drug class cox-2 inhibitors. prior to 30 weeks gestation: Risk cannot be ruled out during pregnancy. starting at 30 weeks gestation: There is positive evidence of human fetal risk during pregnancy. Celecoxib 50 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TEVA 7306

Celecoxib 50 mg TEVA 7306
Celecoxib 50 mg TEVA 7306
Celecoxib 50 mg TEVA 7306
Celecoxib 50 mg TEVA 7306

Celecoxib

Imprint
TEVA 7306
Strength
50 mg
Color
Orange & White
Size
14.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Cox-2 inhibitors
Pregnancy Category
C - Risk cannot be ruled out - prior to 30 weeks gestation, D - Positive evidence of risk - starting at 30 weeks gestation
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA Inc
Inactive Ingredients
ferrosoferric oxide, gelatin, mannitol, povidone k30, propylene glycol, shellac, sodium lauryl sulfate, sodium stearyl fumarate, titanium dioxide, D&C Red No. 28, D&C Yellow No. 10, FD&C Blue No. 1, FD&C Red No. 40, potassium hydroxide

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00093-7306 (Discontinued) Teva Pharmaceuticals USA, Inc.
42291-0192 (Discontinued) AvKare, Inc.
Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer